Immediate Effects of Lipid-Based and Non-Lipid Artificial Tears on Corneal Aberrations

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

March 1, 2025

Study Completion Date

March 15, 2025

Conditions
Aberration, Corneal Wavefront
Interventions
DRUG

Lipid-Based Artificial Tear

This intervention consists of a lipid-based artificial tear formulation containing mineral oil and hydroxypropyl guar. It is designed to enhance the tear film's lipid layer and improve ocular surface stability. Participants in this group will receive a single drop in each eye, and corneal aberrations will be measured at baseline and 15 minutes after instillation.

DRUG

Non-Lipid Artificial Tear

This intervention consists of a non-lipid artificial tear formulation containing hydroxypropyl guar. It is intended to stabilize the aqueous layer of the tear film and maintain optical quality. Participants in this group will receive a single drop in each eye, and corneal aberrations will be measured at baseline and 15 minutes after instillation.

Trial Locations (1)

Unknown

ISEC Lisboa, Lisbon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

University of Seville

OTHER

NCT06784661 - Immediate Effects of Lipid-Based and Non-Lipid Artificial Tears on Corneal Aberrations | Biotech Hunter | Biotech Hunter